ArticlePLoS pathogens2009
Vpu matchmakers as a therapeutic strategy for HIV infection.
Article in PLoS pathogens, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
11 citing papers in PubMed.
- Review
- Viral channel forming proteins--How to assemble and depolarize lipid membranes in silico.Biochimica et biophysica acta · 2016Review
- Viral channel forming proteins - modeling the target.Biochimica et biophysica acta · 2011Review
- Identification of amino acids in the human tetherin transmembrane domain responsible for HIV-1 Vpu interaction and susceptibility.Journal of virology · 2011Article
- Polarity changes in the transmembrane domain core of HIV-1 Vpu inhibits its anti-tetherin activity.PloS one · 2011Article
- Viral replication is enhanced by an HIV-1 intersubtype recombination-derived Vpu protein.Virology journal · 2010Article
- Oligomerization state and supramolecular structure of the HIV-1 Vpu protein transmembrane segment in phospholipid bilayers.Protein science : a publication of the Protein Society · 2010Article
- Ion channels as antivirus targets.Virologica Sinica · 2010Review
- Vpu serine 52 dependent counteraction of tetherin is required for HIV-1 replication in macrophages, but not in ex vivo human lymphoid tissue.Retrovirology · 2010Article
- Novel approaches to inhibiting HIV-1 replication.Antiviral research · 2010Review
- Antiviral activity of the interferon-induced cellular protein BST-2/tetherin.AIDS research and human retroviruses · 2009Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
Abstract
PubMed holds no abstract for this paper.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.